スタッフ ログイン
Japanese |
English
ご質問・ご要望
一覧
検索
生物種別閲覧
登録
統計情報
検索
ホーム
一覧
論文
特許
論文 - 一覧
«
»
10 Hits
検索条件 : 絞込み (MeSH = Immune Checkpoint Inhibitors* / pharmacology)
生物種
リソース名
RRC ID
タイトル
ジャーナル
公開日
外部リンク
ヒト・動物細胞
LA-N-5(RCB0485)
87252
P53-armed Oncolytic Adenovirus Enhances the Efficacy of PD-1 Blockade in Neuroblastoma by Inducing Immunogenic Cell Death.
Anticancer Res
2026-4-1
Pubmed
Full text
実験動物マウス
RBRC09486
86958
IL2/IL15 Signaling Induces NK Cell Production of FLT3LG, Augmenting Anti-PD-1 Immunotherapy.
Cancer Immunol Res
2026-1-8
Pubmed
Full text
ヒト・動物細胞
OV2944-HM-1(RCB1483)
86747
Digital spatial profiling reveals additive effects of triple therapy on tumor microenvironment: anti-PD-L1, anti-VEGF, and PARP inhibition in mouse models.
Cancer Immunol Immunother
2026-2-7
Pubmed
Full text
実験動物マウス
RBRC05737
86435
Preclinical study and phase II trial of adapting low-dose radiotherapy to immunotherapy in small cell lung cancer.
Med
2024-10-11
Pubmed
Full text
実験動物マウス
RBRC09256
85954
Secretory IgA amplification during immune checkpoint blockade enhances the control of tumor growth by enterotropic T cells.
Sci Adv
2025-10-3
Pubmed
Full text
ヒト・動物細胞
B16F10(RCB2630)
85708
Tumor stroma-derived ANGPTL2 potentiates immune checkpoint inhibitor efficacy.
Cancer Gene Ther
2024-6-1
Pubmed
Full text
ヒト・動物細胞
T3M-1 Clone2(RCB1015)
85532
Inosine shapes PD-1 blockade responses and synergizes with dual PD-1/CTLA-4 immunotherapy to enhance antitumor immunity.
Cancer Immunol Immunother
2025-8-19
Pubmed
Full text
ヒト・動物細胞
A549
83131
Lipid-siRNA Conjugates Targeting High PD-L1 Expression as Potential Novel Immune Checkpoint Inhibitors
Biomolecules
2025-2-15
Pubmed
Full text
ヒト・動物細胞
PANC-1(RCB2095)
79227
Blockade of histamine receptor H1 augments immune checkpoint therapy by enhancing MHC-I expression in pancreatic cancer cells.
J Exp Clin Cancer Res
2024-5-8
Pubmed
Full text
ヒト・動物細胞
LLC(RCB0588)
78566
DSP-0509, a systemically available TLR7 agonist, exhibits combination effect with immune checkpoint blockade by activating anti-tumor immune effects.
Front Immunol
2023-1-1
Pubmed
Full text